- Petersen RC, Smith GE, Waring SC, et a/. Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 1999; 56: 303–308
- Petersen RC. Clinical subtypes of Alzheimer's disease. Dement Geriatr Cogn Disord 1998; 9 (Suppl. 3): S16—S24
- Flicker C, Ferris SH, Reisberg B. Mild cognitive impairment in the elderly: Predictors of dementia. Neurology 1991; 41: 1006–1009
- Markesbery WR, Schmitt FA, Kryscio RJ, et al. Neuropathologic substrate of mild cognitive impairment. Arch Neurol 2006; 63: 38-46
- Morris JC. Mild cognitive impairment is early-stage Alzheimer disease: Time to revise diagnostic criteria. Arch Neurol 2006; 63: 15–16
- Yamaguchi H. Illustration of dynamic changes in Alzheimer pathology: From mild cognitive impairment to terminal stage. Neuropathology 2005; 25: 285–287
- Morris JC. Mild cognitive impairment and preclinical Alzheimer's disease. Geriatrics 2005; Suppl.: 9-14
- Smith CD, Chebrolu H, Wekstein DR, et al. Brain structural alterations before mild cognitive impairment. Neurology 2007; 68: 1268-1273
- Smith CD, Chebrolu H, Wekstein DR, etal. Age and gender effects on human brain anatomy: A voxel-based morphometric study in healthy elderly. Neurobiol Aging 2007; 28: 1075–1087
- Braak H, Braak E. Alzheimer's disease starts in early adulthood. Neurobiol Aging 1998; 19: S78
- Braak H, Braak E. Frequency of stages of Alzheimer-related lesions of different age categories. Neurobiol Aging 1997; 18: 351–357
- Good CD, Johnsrude IS, Ashburner J, et al. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 2001; 14: 21–36
- Good CD, Johnsrude I, Ashburner J, etal. Cerebral asymmetry and the effects of sex and handedness on brain structure: A voxel-based morphometric analysis of 465 normal adult human brains. Neuroimage 2001; 14: 685–700
- Andrea M, Price CJ, Friston KJ, et al. Voxel-based morphometry of the human brain: Methods and applications. Curr Med Imaging Rev 2005; 1: 105–113
- Schmitt FA, Wetherby MM, Wekstein DR, etal. Brain donation in normal aging: Procedures, motivations, and donor characteristics from the Biologically Resilient Adults in Neurological Studies (B RAi NS) Project. Gerontologist 2001; 41: 716–722
- Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment — beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004; 256: 240–246
- Liu J, Chelberg D, Smith C, et al. Distribution-based level set segmentation for brain MR Images. Presented at International Conference on Image Processing (ICIP'07), 2007, San Antonio, TX, USA
- Chan T, Vese L. An active contour model without edges. IEEE Trans Image Process 2001; 10: 266–277
- Chan T, Vese L. A level set algorithm for minimizing the Mumford—Shah functional in image processing. Presented at the 1st IEEE Workshop on Variational and Level Set Methods in Computer Vision, 2001, Vancouver, Canada
- Coffey CE, Lucke JF, Saxton JA, et al. Sex differences in brain aging: A quantitative magnetic resonance imaging study. Arch Neurol 1998; 55: 169–179
- Genovese CR, Lazar NA, Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 2002; 15: 870–878
- Smith CD. Mild cognitive impairment is too late: The case for presymtomatic detection and treatment of Alzheimer's disease. Cogn Sci 2007; 3: 33–84
- Gervais F, Paquette J, Morissette C, et al. Targeting soluble Abeta peptide with Tramiprosate for the treatment of brain amyloidosis. Neurobiol Aging 2007; 28: 537–547
- Kukar T, Prescott S, Eriksen JL, et a/. Chronic administration of R-flurbiprofen attenuates learning impairments in transgenic amyloid precursor protein mice. BMC Neurosci 2007; 8: 54
- Linn RT, Wolf PA, Bachman DL, etal. The “preclinical phase” of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort. Arch Neurol 1995; 52: 485–490
- Whalley Li, Starr JM, Athawes R, et al. Childhood mental ability and dementia. Neurology 2000; 55: 1455–1459
- Finehout EJ, Franck Z, Choe LH, et a/. Cerebrospinal fluid proteomic biomarkers for Alzheimer's disease. Ann Neurol 2007; 61: 120–129
- Lovell MA, Gabbita SP, Markesbery WR. Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF. J Neurochem 1999; 72: 771–776
Improved predictive model for pre-symptomatic mild cognitive impairment and Alzheimer's disease
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.